For weight management, it is approved for adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to a reduced-calorie diet and increased physical activity
CLINICAL PRACTICE CONSIDERATIONS Cardiovascular-kidney-metabolic traits The choice between SGLT2 inhibitors and GLP-1 receptor agonists for managing DKD should be guided by a comprehensive assessment of an individuals cardiovascular-kidney-metabolic (CKM) health [83]
PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no insurance required, no membership fees, and full HSA/FSA eligibility
Dose adjustments : If gastrointestinal side effects are problematic, the Wegovy SmPC advises considering slower dose escalation or temporary dose reduction
Despite sharing this mechanism, they are used in different ways: Wegovy is licensed in the UK for weight management, while Trulicity is licensed for type 2 diabetes
To understand how weight loss medications work, it helps to know the difference between an active ingredient and a brand name
